BENZPHETAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Benzphetamine Hydrochloride patents expire, and when can generic versions of Benzphetamine Hydrochloride launch?
Benzphetamine Hydrochloride is a drug marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, and Tedor Pharm. and is included in nine NDAs.
The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benzphetamine Hydrochloride
A generic version of BENZPHETAMINE HYDROCHLORIDE was approved as benzphetamine hydrochloride by KVK TECH on July 20th, 2010.
Summary for BENZPHETAMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Patent Applications: | 1,427 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BENZPHETAMINE HYDROCHLORIDE at DailyMed |
Pharmacology for BENZPHETAMINE HYDROCHLORIDE
Drug Class | Sympathomimetic Amine Anorectic |
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |